Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022

SELL
$8.59 - $20.77 $408,351 - $987,364
-47,538 Reduced 19.05%
202,041 $2.55 Million
Q1 2022

Apr 27, 2022

SELL
$15.52 - $35.65 $1.03 Million - $2.36 Million
-66,090 Reduced 20.94%
249,579 $4.72 Million
Q4 2021

Feb 02, 2022

SELL
$28.89 - $35.33 $828,420 - $1.01 Million
-28,675 Reduced 8.33%
315,669 $11.1 Million
Q3 2021

Oct 25, 2021

SELL
$35.66 - $42.94 $41,579 - $50,068
-1,166 Reduced 0.34%
344,344 $12.6 Million
Q2 2021

Aug 02, 2021

SELL
$23.7 - $39.27 $2.37 Million - $3.92 Million
-99,799 Reduced 22.41%
345,510 $13.6 Million
Q1 2021

Apr 30, 2021

BUY
$27.01 - $36.8 $2.46 Million - $3.35 Million
91,148 Added 25.74%
445,309 $12.6 Million
Q4 2020

Feb 05, 2021

SELL
$27.51 - $34.36 $1.6 Million - $2 Million
-58,138 Reduced 14.1%
354,161 $11.3 Million
Q3 2020

Oct 30, 2020

SELL
$25.8 - $34.61 $1.59 Million - $2.13 Million
-61,658 Reduced 13.01%
412,299 $13.3 Million
Q2 2020

Jul 27, 2020

SELL
$17.65 - $28.05 $456,799 - $725,962
-25,881 Reduced 5.18%
473,957 $13.1 Million
Q1 2020

Apr 27, 2020

BUY
$15.19 - $29.51 $476,115 - $924,961
31,344 Added 6.69%
499,838 $8.92 Million
Q4 2019

Jan 31, 2020

BUY
$17.17 - $25.95 $221,596 - $334,910
12,906 Added 2.83%
468,494 $11.7 Million
Q3 2019

Oct 31, 2019

BUY
$17.84 - $22.69 $2.28 Million - $2.9 Million
127,979 Added 39.06%
455,588 $8.13 Million
Q2 2019

Jul 29, 2019

SELL
$22.0 - $31.78 $2.37 Million - $3.43 Million
-107,919 Reduced 24.78%
327,609 $7.21 Million
Q1 2019

May 08, 2019

BUY
$21.27 - $30.58 $1.15 Million - $1.65 Million
54,002 Added 14.15%
435,528 $13.3 Million
Q4 2018

Feb 06, 2019

BUY
$23.09 - $37.69 $5.73 Million - $9.35 Million
248,047 Added 185.83%
381,526 $8.84 Million
Q3 2018

Nov 07, 2018

BUY
$26.55 - $34.38 $319,900 - $414,244
12,049 Added 9.92%
133,479 $4.3 Million
Q2 2018

Aug 01, 2018

BUY
$27.79 - $34.49 $370,857 - $460,269
13,345 Added 12.35%
121,430 $3.66 Million
Q4 2017

Feb 06, 2018

SELL
$27.41 - $39.42 $1.17 Million - $1.68 Million
-42,576 Reduced 28.26%
108,085 $4.26 Million
Q3 2017

Nov 07, 2017

SELL
$22.15 - $27.5 $1.26 Million - $1.56 Million
-56,905 Reduced 27.42%
150,661 $4.11 Million
Q2 2017

Aug 07, 2017

BUY
N/A
207,566
207,566 $4.84 Million

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $2.47B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.